Company
Liquidia Corp (LQDA)
Standardized SEC financial data for Liquidia Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001819576 · NASDAQ · Pharmaceutical Preparations.
Gross margin
5.1%
Operating margin
-32.5%
Net margin
-43.5%
Revenue growth (YoY)
1031.2%
Return on equity
-154.0%
Free cash flow
-$40.0M
Debt / equity
0.44×
Current ratio
2.01×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $740K | $12.9M | $15.9M | $17.5M | $14.0M | $158.3M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $65.3M | $57.5M | $93.3M | $83.7M | $176.5M | $190.7M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$54.1M | -$34.0M | -$28.6M | -$41.6M | -$93.4M | -$35.7M |
| Capital expenditures |
Get LQDA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LQDA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LQDA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"